Roles of adenosine receptor subtypes on the antinociceptive effect of sildenafil in rat spinal cord

2010 ◽  
Vol 480 (3) ◽  
pp. 182-185 ◽  
Author(s):  
Hyung Gon Lee ◽  
Woong Mo Kim ◽  
Jeong Il Choi ◽  
Myung Ha Yoon
1999 ◽  
Vol 81 (3) ◽  
pp. 264-270
Author(s):  
Azusa Sugimoto-Watanabe ◽  
Kazufumi Kubota ◽  
Kenji Fujibayashi ◽  
Koji Saito

Pharmacology ◽  
2006 ◽  
Vol 78 (1) ◽  
pp. 21-26 ◽  
Author(s):  
Myung Ha Yoon ◽  
Hong Beom Bae ◽  
Jeong Il Choi ◽  
Seok Jai Kim ◽  
Sung Tae Chung ◽  
...  

2002 ◽  
Vol 11 (3) ◽  
pp. 229-239 ◽  
Author(s):  
Christopher A. Willson ◽  
Margarita Irizarry-Ramírez ◽  
Hope E. Gaskins ◽  
Lillian Cruz-Orengo ◽  
Johnny D. Figueroa ◽  
...  

After spinal cord injury (SCI), the inability of supraspinal neurons to regenerate or reform functional connections is likely due to proteins in the surrounding microenvironment restricting regeneration. EphAs are a family of receptor tyrosine kinases that are involved in axonal guidance during development. These receptors and their ligands, the Ephrins, act via repulsive mechanisms to guide growing axons towards their appropriate targets and allow for the correct developmental connections to be made. In the present study, we investigated whether EphA receptor expression changed after a thoracic contusion SCI. Our results indicate that several EphA molecules are upregulated after SCI. Using semiquantitative RT-PCR to investigate mRNA expression after SCI, we found that EphA3, A4, and A7 mRNAs were upregulated. EphA3, A4, A6, and A8 receptor immunoreactivity increased in the ventrolateral white matter (VWM) at the injury epicenter. EphA7 had the highest level of immunoreactivity in both control and injured rat spinal cord. EphA receptor expression in the white matter originated from glial cells as coexpression in both astrocytes and oligodendrocytes was observed. In contrast, gray matter expression was localized to neurons of the ventral gray matter (motor neurons) and dorsal horn. After SCI, specific EphA receptor subtypes are upregulated and these increases may create an environment that is unfavorable for neurite outgrowth and functional regeneration.


2002 ◽  
Vol 133 (2) ◽  
pp. 93-104 ◽  
Author(s):  
Yi Huang ◽  
W.Daniel Stamer ◽  
Todd L Anthony ◽  
David V Kumar ◽  
Paul A St. John ◽  
...  

2006 ◽  
Vol 70 (1) ◽  
pp. 99-102 ◽  
Author(s):  
Eiichiro Umeda ◽  
Yoshihiko Aramaki ◽  
Tomohisa Mori ◽  
Tomiei Kazama

2021 ◽  
Author(s):  
Shaaban Mousa ◽  
Mohammed Shaqura ◽  
Baled Khalefa ◽  
Li Li ◽  
Mohammed Al-madol ◽  
...  

Abstract Corticotropin-releasing factor (CRF) orchestrates our body’s response to stressful stimuli. Pain is often stressful and counterbalanced by activation of CRF receptors along the nociceptive pathway, although the involvement of the CRF receptors of subtypes 1 and/or 2 (CRF-R1 and CRF-R2, respectively) in CRF-induced analgesia remains controversial. This study aimed to examine CRF-R1 and CRF-R2 expression within spinal cord of rats with Freund’s complete adjuvant-induced hindpaw inflammation using reverse transcriptase polymerase chain reaction, Western blot, radioligand binding, and immunofluorescence confocal analysis, Western blot, immunohistochemistry, and radioligand binding. Moreover, paw pressure algesiometry examined antinociceptive effects of intrathecal (i.t.) CRF and their possible antagonism through CRF-R1 and/or CRF-R2 selective antagonists as well as opioid receptor antagonist naloxone. Our results demonstrated mainly CRF-R2 mRNA, protein, binding sites and immunoreactivity in dorsal horn of rat spinal cord. In parallel, i.t. CRF as well as CRF-R2 agonists elicited potent antinociceptive effects which are dose-dependent and antagonized exclusively by i.t. CRF-R2 (K41498), but not CRF-R1 (NBI35965) antagonist. Moreover, i.t. CRF elicited inhibition of somatic pain that was dose-dependently reversed by the opioid antagonist naloxone. Consistently, double immunofluorescence confocal microscopy showed CRF-R2 on enkephalin (ENK) containing inhibitory interneurons in close opposition of incoming, mu-opioid receptor-immunoreactive nociceptive neurons but not on pre- nor on postsynaptic sensory neurons of the spinal cord. Taken together, these findings suggest that i.t. CRF or CRF-R2 agonist inhibits inflammatory somatic pain which occurs most predominantly through CRF-R2 receptors located on spinal enkephalinergic inhibitory interneurons resulting in endogenous opioid-mediated pain inhibition.


Sign in / Sign up

Export Citation Format

Share Document